<DOC>
	<DOCNO>NCT03020940</DOCNO>
	<brief_summary>1 . National , large-scale , standardized , standardized , real-world research ; 2 . Prospective , single - arm open , non - interventional , registration , multi - center clinical study ; 3. use cefuroxime axetil dispersible tablet hospital , accord principle voluntary selection 200 ; 4. registration use cefuroxime axetil dispersion tablet patient ; 5 . Target sample size 100,000 case ; 6 . Exemption inform consent ethical review application ; 7 . Antibiotic drug safety re-evaluation large data .</brief_summary>
	<brief_title>The Clinical Trial Cefuroxime Axetil Dispersible Tablets</brief_title>
	<detailed_description>Research purpose 1 . To evaluate safety cefuroxime axetil dispersible tablet real world widely use population , Rare even rare , new , unanticipated adverse reaction , reveal adverse reaction Should susceptible risk factor susceptible population . 2 . To evaluate efficacy cefuroxime axetil dispersible tablet treatment relevant site infection , include Including empirical therapy target therapy , evaluate widespread use cefuroxime dispersible tablets The validity crowd real world . 3 . To investigate clinical application cefuroxime axetil dispersible tablet safety management drug use . Clinical management provide clinical clue basis . 4 . For relevant treatment area guidance consensus revision , clinical pathway design provide reference . 5 . To improve safety cefuroxime axetil dispersion tablet level , basic medical security capability Market vitality . Study end point 1 . The main study endpoint : - Security ; - Effectiveness . 2 . Secondary study endpoint : - Extensive use population characteristic ; - Clinical drug characteristic ; - Appropriate characteristic crowd ; - Adverse reaction susceptible population characteristic .</detailed_description>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Cefuroxime axetil</mesh_term>
	<mesh_term>Cefuroxime</mesh_term>
	<criteria>Prescription cefuroxime axetil dispersible tablet patient</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>